Calamos Advisors
OCEA

Calamos Advisors’s Ocean Biomedical, Inc. Common Stock OCEA Stock Holding History

Calamos Advisors’s Portfolio OCEA Stock Details OCEA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-125,000
Closed -$1.3M – 1225
2022
Q4 		$1.3M Hold
125,000
– – 0.01% 837
2022
Q3 		$1.27M Buy
+125,000
New +$1.27M 0.01% 919

Other funds holding OCEA

PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MC
Meteora Capital Boca Raton, Florida $1.36B AUM 21.19% 1-Year Est. Return
CCFM
Cohen & Co Financial Management New York $18.3M AUM 73.48% 1-Year Est. Return
QL
Quarry LP New York $558M AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
CSS
Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
AI
Arena Investors Purchase, New York $12.5M AUM 0.27% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Calamos Advisors's OCEA Position: Q1 2023 in Review

Calamos Advisors sold out of Ocean Biomedical, Inc. Common Stock (OCEA) in Q1 2023, closing a stake of 125,000 shares — an estimated $1.3M sold.

Calamos Advisors first reported a position in OCEA in Q3 2022 and held it in 2 quarters. The position peaked at $1.3M in Q4 2022. 17 funds tracked by Wall St. Rank hold OCEA as of Q1 2023.

  • Calamos Advisors reported no remaining Ocean Biomedical, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Calamos Advisors sold 125,000 Ocean Biomedical, Inc. Common Stock shares in Q1 2023, an estimated $1.3M.
  • Calamos Advisors first reported a position in Ocean Biomedical, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • Calamos Advisors's Ocean Biomedical, Inc. Common Stock position peaked at $1.3M in Q4 2022.
  • 17 funds tracked by Wall St. Rank held Ocean Biomedical, Inc. Common Stock as of Q1 2023.

Based on Calamos Advisors's 13F filing for Q1 2023, filed 4 May 2023.